Novartis AGNVSNYSE
Loading
Year-over-year free cash flow growth rate
Percentile
P3
Near historical low
vs 5Y Ago
-4x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -71.38% |
| Q3 2025 | -5.99% |
| Q2 2025 | 183.87% |
| Q1 2025 | -29.75% |
| Q4 2024 | -44.20% |
| Q3 2024 | 32.31% |
| Q2 2024 | 273.94% |
| Q1 2024 | -48.20% |
| Q4 2023 | -59.31% |
| Q3 2023 | 96.49% |
| Q2 2023 | 7.68% |
| Q1 2023 | -28.20% |
| Q4 2022 | -18.47% |
| Q3 2022 | 33.95% |
| Q2 2022 | 301.52% |
| Q1 2022 | -72.82% |
| Q4 2021 | -33.72% |
| Q3 2021 | 24.07% |
| Q2 2021 | 177.91% |
| Q1 2021 | -57.34% |
| Q4 2020 | 17.91% |
| Q3 2020 | -27.93% |
| Q2 2020 | 71.34% |
| Q1 2020 | -29.48% |
| Q4 2019 | -27.35% |
| Q3 2019 | 49.64% |
| Q2 2019 | 48.97% |
| Q1 2019 | -37.24% |
| Q4 2018 | -10.97% |
| Q3 2018 | -3.40% |
| Q2 2018 | 93.59% |
| Q1 2018 | -29.61% |
| Q4 2017 | -16.42% |
| Q3 2017 | -2.38% |
| Q2 2017 | 127.74% |
| Q1 2017 | -51.03% |
| Q4 2016 | 18.96% |
| Q3 2016 | -7.55% |
| Q2 2016 | 192.44% |
| Q1 2016 | -70.70% |